Taysha gene therapies presents new preclinical in-vitro data on tsha-102 in rett syndrome supporting mirare regulation of mecp2 expression at the european society of gene & cell therapy (esgct) 30th annual congress

In vitro data demonstrated the mirare control element downregulates mecp2 transgene and protein expression in response to cellular levels of mecp2 in cell culture models

TSHA Ratings Summary

TSHA Quant Ranking